CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD 3.630
+0.080 (2.25%)
Jul 31, 2026, 3:32 PM EST
CareRx Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 230 | 240 | 128 | 96 | 131 | 263 | |
Market Cap Growth | 28.64% | 87.31% | 32.92% | -26.22% | -50.43% | 176.67% |
Enterprise Value | 297.15 | 303.83 | 201.58 | 187.16 | 237.42 | 359.2 |
Last Close Price | 3.63 | 3.82 | 2.06 | 1.61 | 2.56 | 5.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.66 | 9.32 | - | - | - | - |
Forward PE | 18.00 | 22.74 | 42.21 | 40.72 | 260.50 | 299.40 |
PS Ratio | 0.61 | 0.65 | 0.35 | 0.26 | 0.34 | 1.00 |
PB Ratio | 2.10 | 2.19 | 1.52 | 1.18 | 2.03 | 3.20 |
P/TBV Ratio | 25.69 | 23.23 | - | - | - | - |
P/FCF Ratio | 9.33 | 9.51 | 3.95 | 4.25 | 10.62 | 137.32 |
P/OCF Ratio | 7.61 | 7.78 | 3.37 | 3.52 | 5.85 | 36.23 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.79 | 0.82 | 0.55 | 0.50 | 0.62 | 1.37 |
EV/EBITDA Ratio | 10.20 | 10.68 | 8.50 | 7.59 | - | 29.72 |
EV/EBIT Ratio | 26.66 | 30.04 | 44.55 | 40.08 | - | - |
EV/FCF Ratio | 12.03 | 12.04 | 6.22 | 8.26 | 19.32 | 187.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.62 | 0.64 | 0.88 | 1.04 | 1.94 | 1.58 |
Debt / EBITDA Ratio | 2.62 | 2.74 | 3.48 | 3.97 | - | 10.88 |
Debt / FCF Ratio | 3.09 | 3.09 | 2.55 | 4.32 | 11.00 | 68.53 |
Net Debt / Equity Ratio | 0.61 | 0.59 | 0.87 | 1.11 | 1.66 | 1.16 |
Net Debt / EBITDA Ratio | 2.29 | 2.25 | 3.10 | 3.69 | -56.87 | 7.93 |
Net Debt / FCF Ratio | 2.70 | 2.54 | 2.27 | 4.01 | 8.69 | 49.95 |
Asset Turnover | 1.55 | 1.59 | 1.61 | 1.49 | 1.39 | 1.20 |
Inventory Turnover | 14.26 | 14.73 | 13.86 | 13.32 | 14.19 | 14.10 |
Quick Ratio | 0.70 | 0.74 | 0.67 | 0.69 | 1.03 | 1.39 |
Current Ratio | 1.08 | 1.06 | 0.99 | 1.05 | 1.40 | 1.80 |
Return on Equity (ROE) | 24.53% | 26.97% | -5.43% | -7.40% | -46.82% | -48.57% |
Return on Assets (ROA) | 25.40% | 33.79% | 2.00% | 1.06% | -7.67% | -1.44% |
Return on Invested Capital (ROIC) | 35.27% | 47.57% | 2.76% | 1.53% | -12.02% | -2.48% |
Return on Capital Employed (ROCE) | 6.16% | 5.94% | 2.74% | 2.52% | -10.19% | -1.93% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.66% | 10.73% | - | - | - | - |
FCF Yield | 10.72% | 10.52% | 25.31% | 23.51% | 9.41% | 0.73% |
Dividend Yield | 2.20% | 0.53% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 14.09% | 4.82% | 0.00% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | -5.06% | -7.03% | -5.06% | -20.20% | -36.88% | -72.00% |
Total Shareholder Return | -2.86% | -6.51% | -5.06% | -20.20% | -36.88% | -72.00% |